8:12 am RedHill Biopharma and IntelGenx submit response to FDA CRL for RHB-103 Migraine oral-film; cos believe that their response to the FDA addresses all the issues raised in the CRL – HedgeChatter

8:12 am RedHill Biopharma and IntelGenx submit response to FDA CRL for RHB-103 Migraine oral-film; cos believe that their response to the FDA addresses all the issues raised in the CRL

03 Mar

8:12 am RedHill Biopharma and IntelGenx submit response to FDA CRL for RHB-103 Migraine oral-film; cos believe that their response to the FDA addresses all the issues raised in the CRL

Bystocknews RDHL, stock Comments Off

View todays social media effects on RDHL

View the latest stocks trending across Twitter. Click to view dashboard

See who Redhill is hiring next, click here to view

Author